These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18410962)

  • 1. Anti-CD20 (rituximab) treatment for atopic eczema.
    Sedivá A; Kayserová J; Vernerová E; Poloucková A; Capková S; Spísek R; Bartůnková J
    J Allergy Clin Immunol; 2008 Jun; 121(6):1515-6; author reply 1516-7. PubMed ID: 18410962
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-CD20 (rituximab) treatment improves atopic eczema.
    Simon D; Hösli S; Kostylina G; Yawalkar N; Simon HU
    J Allergy Clin Immunol; 2008 Jan; 121(1):122-8. PubMed ID: 18206507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
    Belloni B; Ziai M; Lim A; Lemercier B; Sbornik M; Weidinger S; Andres C; Schnopp C; Ring J; Hein R; Ollert M; Mempel M
    J Allergy Clin Immunol; 2007 Nov; 120(5):1223-5. PubMed ID: 17936892
    [No Abstract]   [Full Text] [Related]  

  • 4. Omalizumab efficacy in a girl with atopic eczema.
    Caruso C; Gaeta F; Valluzzi RL; Romano A
    Allergy; 2010 Feb; 65(2):278-9. PubMed ID: 19796201
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
    Amrol D
    South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab for patients with severe and therapy-refractory atopic eczema?
    Andres C; Belloni B; Mempel M; Ring J
    Curr Allergy Asthma Rep; 2008 May; 8(3):179-80. PubMed ID: 18589835
    [No Abstract]   [Full Text] [Related]  

  • 7. Omalizumab treatment in severe adult atopic dermatitis.
    Thaiwat S; Sangasapaviliya A
    Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of anti-IgE therapy in patients with atopic dermatitis.
    Vigo PG; Girgis KR; Pfuetze BL; Critchlow ME; Fisher J; Hussain I
    J Am Acad Dermatol; 2006 Jul; 55(1):168-70. PubMed ID: 16781320
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of atopic-like dermatitis by treatment with antibody to lymphocyte function-associated antigen-1 in NC/Nga mouse.
    Ohmura T; Konomi A; Satoh Y; Hayashi T; Tsunenari I; Kadota T; Panzenbeck MJ; Satoh H
    Eur J Pharmacol; 2004 Nov; 504(1-2):113-7. PubMed ID: 15507227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study.
    Heil PM; Maurer D; Klein B; Hultsch T; Stingl G
    J Dtsch Dermatol Ges; 2010 Dec; 8(12):990-8. PubMed ID: 20678148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic skin diseases.
    Fox RW
    J Fla Med Assoc; 1996; 83(6):394-7. PubMed ID: 8752365
    [No Abstract]   [Full Text] [Related]  

  • 12. Atopic dermatitis is an important comorbidity in severe asthma.
    Lee JK; Han D
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):661-662. PubMed ID: 29496463
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel immunological approaches in the treatment of atopic eczema.
    Belloni B; Andres C; Ollert M; Ring J; Mempel M
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):423-7. PubMed ID: 18769195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of atopic dermatitis].
    Bakos N; Nékám K
    Orv Hetil; 2003 Aug; 144(34):1689-91. PubMed ID: 14528844
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E.
    Quist SR; Ambach A; Göppner D; Quist J; Franke I; Bonnekoh B; Gollnick HP
    Acta Derm Venereol; 2013 Mar; 93(2):206-8. PubMed ID: 23042516
    [No Abstract]   [Full Text] [Related]  

  • 16. Proactive therapy of atopic dermatitis--an emerging concept.
    Wollenberg A; Bieber T
    Allergy; 2009 Feb; 64(2):276-8. PubMed ID: 19076538
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-31 pathway and its role in atopic dermatitis: a systematic review.
    Saleem MD; Oussedik E; D'Amber V; Feldman SR
    J Dermatolog Treat; 2017 Nov; 28(7):591-599. PubMed ID: 28145790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of solar urticaria with anti-immunoglobulin E therapy.
    Güzelbey O; Ardelean E; Magerl M; Zuberbier T; Maurer M; Metz M
    Allergy; 2008 Nov; 63(11):1563-5. PubMed ID: 18925897
    [No Abstract]   [Full Text] [Related]  

  • 19. New drug targets in atopic dermatitis.
    Simon D; Simon HU
    Chem Immunol Allergy; 2012; 96():126-131. PubMed ID: 22433382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab and omalizumab in severe, refractory insulin allergy.
    Yong PF; Malik R; Arif S; Peakman M; Amiel S; Ibrahim MA; Gough A
    N Engl J Med; 2009 Mar; 360(10):1045-7. PubMed ID: 19264698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.